Cancer diagnoses in adolescents in young adults are rising. These patients are not only navigating the challenges of a life-altering diagnosis, but also other challenges distinct to their life stage.
University of Oxford researchers have leveraged the power of artificial intelligence (AI) to develop personalized cancer treatments which could be more effective at preventing patient relapse.
OpenAI’s GPT-4o artificial intelligence (AI) model is powering a copilot application designed to accelerate cancer patients’ access to treatment by identifying missing diagnostics and creating tailored workup plans. Developed by Color…
Figures come amid record dissatisfaction with GPs and long waits for diagnostic tests, with patients often struggling to be seen. Cancer Research UK described the situation as 'unacceptable'.
Cross-border tumor boards of cancer specialists from different European countries meeting virtually to review the management of individual patients with complex rare gynecological cancers from across Europe resulted in new treatment…
AstraZeneca Plc (NASDAQ:AZN) released data from the ECHO Phase 3 trial of Calquence (acalabrutinib) plus bendamustine and rituximab compared to standard-of-care chemoimmunotherapy (bendamustine and rituximab) in adult patients at or over…
Tegretol, Salbutomol, Ozempic and Creon were among 70 medications out of stock in the last week of May alone - with many not set to be restocked in pharmacies until October
Urgent cancer and transplant operations were among the 814 procedures cancelled following a Russian cyber attack on hospitals earlier this month, the NHS has admitted.
Results from a new phase 1 trial indicate that immunotherapy could be used to treat the most common form of colorectal cancer, also known as bowel cancer. Consistent responses to immunotherapy have been reported in patients with the most…